Adjusted EBITDA was $336 million, down year-over-year but improved sequentially due to higher volumes and cost savings.
Albemarle reported Q2 2025 net sales of $1.3 billion, with strong volume growth in energy storage and specialties but a year-over-year decline mainly due to lower lithium market pricing.
Capital expenditures were reduced by about 60% year-over-year to a range of $650 million to $700 million.
Corporate EBITDA improved primarily due to cost reductions and foreign exchange gains.
Liquidity remained strong with $3.4 billion available, including $1.8 billion in cash and $1.5 billion revolver availability.
Net debt to adjusted EBITDA ratio improved to 2.3x, well below covenant limits.
SG&A costs decreased by more than 20% year-over-year due to cost savings initiatives.
Specialties EBITDA increased by 35% year-over-year driven by higher volumes, pricing, and reduced costs.
The company achieved a 100% run rate of its $400 million cost and productivity improvement target by June 2025.
Dafinchi